The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain medication that doesn't carry the risks of addiction and ...
WASHINGTON: Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
De voordelen van GLP-1-agonisten zijn groter dan de risico’s die bij het nemen van deze medicijnen komen kijken. Tenminste, ...